Suppr超能文献

阿尔茨海默病蛋白(A68)与tau蛋白具有共同表位,但表现出不同的生化特性。

Alzheimer disease proteins (A68) share epitopes with tau but show distinct biochemical properties.

作者信息

Ksiezak-Reding H, Binder L I, Yen S H

机构信息

Department of Pathology, Albert Einstein College of Medicine, Bronx, New York 10461.

出版信息

J Neurosci Res. 1990 Mar;25(3):420-30. doi: 10.1002/jnr.490250320.

Abstract

Alz 50, a monoclonal antibody raised against Alzheimer brain homogenate, reacts with neurofibrillary tangles, microtubule-associated proteins tau, and Alzheimer brain proteins of molecular weight 70-60 kDa (A68). To study the relationship between A68 and normal human tau we compared the biochemical properties of these proteins and tested the reactivity of A68 with eight antibodies (Alz 50, Tau 60, Tau-2, Tau 14, Tau-1, Ab 636.7, NP14, Tau 46) that bind to various regions of tau molecule. On Western blots, all tau-reactive antibodies, except Tau-1, recognized A68. Pretreatment with alkaline phosphatase was required for the Tau-1 binding to A68. A68 consisted of three polypeptides of 68, 64, and 60 kDa, while tau contained 4-6 polypeptides of 50-65 kDa. A68 was less heterogenous than tau in the number of pI variants on two-dimensional gels. All A68 variants were more acidic (pI 5.5-6.5) than human tau (pI 6.5-8.5). Phosphatase treatment had only a minor effect on the pI and mobility of A68. Limited proteolysis of A68 with trypsin or chymotrypsin generated large fragments of 56-66 kDa (chymotrypsin) and 40-45 kDa (trypsin). While none of the fragments was recognized by Alz 50, the chymotryptic fragments were reactive with all the other tau antibodies, and the tryptic fragments were positive with five of the antibodies (Tau 14, Tau-1, Ab 636.7, NP14, and Tau 46). The peptide maps of A68 differed from that of tau in the number and the size of the peptide fragments. The differences in biochemical properties of these proteins and the sharing multiple epitopes suggest that A68 is a modified form of tau. The modification in part may be due to phosphorylation, although other changes rendering different isoelectrical properties and susceptibility to proteases need to be considered. The removal of the Alz 50 epitope by a cleavage of a 2-3 kDa fragment which does not contain the most C-terminal epitope (Tau 46) indicates that the Alz 50 epitope is located at the N-terminal periphery of the A68 molecule.

摘要

Alz 50是一种针对阿尔茨海默病脑匀浆产生的单克隆抗体,可与神经原纤维缠结、微管相关蛋白tau以及分子量为70 - 60 kDa的阿尔茨海默病脑蛋白(A68)发生反应。为了研究A68与正常人tau之间的关系,我们比较了这些蛋白质的生化特性,并测试了A68与八种可结合tau分子不同区域的抗体(Alz 50、Tau 60、Tau - 2、Tau 14、Tau - 1、Ab 636.7、NP14、Tau 46)的反应性。在蛋白质印迹法中,除Tau - 1外,所有与tau反应的抗体都能识别A68。Tau - 1与A68结合需要用碱性磷酸酶进行预处理。A68由分子量为68 kDa、64 kDa和60 kDa的三种多肽组成,而tau包含4 - 6种分子量为50 - 65 kDa的多肽。在二维凝胶上,A68的等电点变体数量比tau少。所有A68变体的酸性都比人tau更强(A68的等电点为5.5 - 6.5,人tau的等电点为6.5 - 8.5)。磷酸酶处理对A68的等电点和迁移率影响较小。用胰蛋白酶或糜蛋白酶对A68进行有限的蛋白水解,产生了分子量为56 - 66 kDa(糜蛋白酶)和40 - 45 kDa(胰蛋白酶)的大片段。虽然Alz 50不能识别任何片段,但糜蛋白酶消化产生的片段能与所有其他tau抗体发生反应,胰蛋白酶消化产生的片段能与五种抗体(Tau 14、Tau - 1、Ab 636.7、NP14和Tau 46)发生反应。A68的肽图在肽片段的数量和大小上与tau不同。这些蛋白质在生化特性上的差异以及共享多个表位表明A68是tau的一种修饰形式。这种修饰部分可能是由于磷酸化,不过还需要考虑其他导致不同等电特性和蛋白酶敏感性的变化。通过切割一个不包含最末端表位(Tau 46)的2 - 3 kDa片段去除Alz 50表位,这表明Alz 50表位位于A68分子的N端周边。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验